Marie Arsenian Henriksson is professor of molecular tumour biology at Karolinska Institutet since 2010.
Her research focuses on the so-called MYC genes, which are activated in at least a third of all cancers, including lymphoma, breast cancer and neuroblastoma. Neuroblastoma is the second most lethal childhood cancer after leukaemia, and where amplification of the MYCN gene (N for neuro) is associated with a worse prognosis.
Research into the MYC genes aims at increased knowledge of how these genes function under normal conditions and contribute to the development of tumor diseases. Knowledge that is important for the development of new, tailored cancer treatments.